3091.7000 -52.40 (-1.67%)
NSE Oct 28, 2025 15:31 PM
Volume: 110.4K
 

ICICI Securities Limited
Dr Lal Pathlabs’ (Dr Lal) Q2FY23 performance was a mixed bag with slower-than-
expected growth in non-covid patient volumes, but healthy improvement in margins.
Dr. Lal Pathlabs Ltd. has an average target of 3111.40 from 5 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended